55714-2538 NDC - VITALITY (ECHINACEA, LAPPA MAJOR, SOLIDAGO VIRGAUREA, TARAXACUM OFFICINALE, ADRENALINUM, ALOE, ARSENICUM ALBUM, BAPTISIA TINCTORIA, BERBERIS AQUIFOLIUM, BERBERIS VULGARIS, BRYONIA, CHELIDONIUM MAJUS, CROTALUS HORRIDUS, DIGITALIS PURPUREA, FERRUM METALLICUM, GLONOINUM, HYDROCOTYLE ASIATICA, IODIUM, IRIS VERSICOLOR, LACHESIS MUTUS, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, NUX VOMICA, RHUS TOXICODENDRON, RUTA GRAVEOLENS, THUJA OCCIDENTALIS, THYROIDINUM, GLYCYRRHIZA GLABRA)

Drug Information

Product NDC: 55714-2538

Proprietary Name: Vitality

Non Proprietary Name: Echinacea, Lappa major, Solidago virgaurea, Taraxacum officinale, Adrenalinum, Aloe, Arsenicum album, Baptisia tinctoria, Berberis aquifolium, Berberis vulgaris, Bryonia, Chelidonium majus, Crotalus horridus, Digitalis purpurea, Ferrum metallicum, Glonoinum, Hydrocotyle asiatica, Iodium, Iris versicolor, Lachesis mutus, Lycopodium clavatum, Natrum muriaticum, Nux vomica, Rhus toxicodendron, Ruta graveolens, Thuja occidentalis, Thyroidinum, Glycyrrhiza glabra

Active Ingredient(s):
  • 15 [hp_X]/mL ALOE;
  • 6 [hp_X]/mL ARCTIUM LAPPA ROOT;
  • 15 [hp_X]/mL ARSENIC TRIOXIDE;
  • 15 [hp_X]/mL BAPTISIA TINCTORIA ROOT;
  • 15 [hp_X]/mL BERBERIS AQUIFOLIUM ROOT BARK;
  • 15 [hp_X]/mL BERBERIS VULGARIS ROOT BARK;
  • 15 [hp_X]/mL BRYONIA ALBA ROOT;
  • 15 [hp_X]/mL CENTELLA ASIATICA;
  • 15 [hp_X]/mL CHELIDONIUM MAJUS;
  • 15 [hp_X]/mL CROTALUS HORRIDUS HORRIDUS VENOM;
  • 15 [hp_X]/mL DIGITALIS;
  • 6 [hp_X]/mL ECHINACEA, UNSPECIFIED;
  • 15 [hp_X]/mL EPINEPHRINE;
  • 16 [hp_X]/mL GLYCYRRHIZA GLABRA;
  • 15 [hp_X]/mL IODINE;
  • 15 [hp_X]/mL IRIS VERSICOLOR ROOT;
  • 15 [hp_X]/mL IRON;
  • 15 [hp_X]/mL LACHESIS MUTA VENOM;
  • 15 [hp_X]/mL LYCOPODIUM CLAVATUM SPORE;
  • 15 [hp_X]/mL NITROGLYCERIN;
  • 15 [hp_X]/mL RUTA GRAVEOLENS FLOWERING TOP;
  • 15 [hp_X]/mL SODIUM CHLORIDE;
  • 6 [hp_X]/mL SOLIDAGO VIRGAUREA FLOWERING TOP;
  • 15 [hp_X]/mL STRYCHNOS NUX-VOMICA SEED;
  • 6 [hp_X]/mL TARAXACUM OFFICINALE;
  • 15 [hp_X]/mL THUJA OCCIDENTALIS LEAFY TWIG;
  • 15 [hp_X]/mL THYROID, UNSPECIFIED;
  • 15 [hp_X]/mL TOXICODENDRON PUBESCENS LEAF


Administration Route(s): ORAL

Dosage Form(s): LIQUID

Pharmacy Class(es):
  • Adrenergic alpha-Agonists [MoA];
  • Adrenergic beta-Agonists [MoA];
  • Allergens [CS];
  • Allergens [CS];
  • Catecholamine [EPC];
  • Catecholamines [CS];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Dietary Proteins [CS];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased IgG Production [PE];
  • Increased Large Intestinal Motility [PE];
  • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE];
  • Nitrate Vasodilator [EPC];
  • Nitrates [CS];
  • Non-Standardized Food Allergenic Extract [EPC];
  • Non-Standardized Plant Allergenic Extract [EPC];
  • Non-Standardized Plant Allergenic Extract [EPC];
  • Osmotic Activity [MoA];
  • Osmotic Laxative [EPC];
  • Plant Proteins [CS];
  • Plant Proteins [CS];
  • Seed Storage Proteins [CS];
  • Vasodilation [PE];
  • alpha-Adrenergic Agonist [EPC];
  • beta-Adrenergic Agonist [EPC]

Labeler Information

Labeler Name: Newton Laboratories, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:1/1/2019

Package Information

No. Package Code Package Description Billing Unit
155714-2538-130 mL in 1 BOTTLE, GLASS (55714-2538-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC55714-2538The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEVitalityThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEEchinacea, Lappa major, Solidago virgaurea, Taraxacum officinale, Adrenalinum, Aloe, Arsenicum album, Baptisia tinctoria, Berberis aquifolium, Berberis vulgaris, Bryonia, Chelidonium majus, Crotalus horridus, Digitalis purpurea, Ferrum metallicum, Glonoinum, Hydrocotyle asiatica, Iodium, Iris versicolor, Lachesis mutus, Lycopodium clavatum, Natrum muriaticum, Nux vomica, Rhus toxicodendron, Ruta graveolens, Thuja occidentalis, Thyroidinum, Glycyrrhiza glabraThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE1/1/2019This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMENewton Laboratories, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEALOE; ARCTIUM LAPPA ROOT; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; BERBERIS AQUIFOLIUM ROOT BARK; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CENTELLA ASIATICA; CHELIDONIUM MAJUS; CROTALUS HORRIDUS HORRIDUS VENOM; DIGITALIS; ECHINACEA, UNSPECIFIED; EPINEPHRINE; GLYCYRRHIZA GLABRA; IODINE; IRIS VERSICOLOR ROOT; IRON; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; NITROGLYCERIN; RUTA GRAVEOLENS FLOWERING TOP; SODIUM CHLORIDE; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE; THUJA OCCIDENTALIS LEAFY TWIG; THYROID, UNSPECIFIED; TOXICODENDRON PUBESCENS LEAFAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 16; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 6; 15; 15; 15 
ACTIVE INGRED UNIT[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL 
PHARM CLASSESAdrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vasodilation [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023